Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
Get Alerts FOLD Hot Sheet
Join SI Premium – FREE
PHILADELPHIA, May 28, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference, being held virtually on Wednesday, June 9, 2021 at 5:30 p.m. E.T.
A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn.
CONTACT:
Investors:Andrew FaughnanSr. Director, Investor Relations[email protected](609) 662-3809
Media:Diana MooreHead of Global Corporate Communications[email protected](609) 662-5079
FOLD–G
Source: Amicus Therapeutics, Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Progress on ABN AMRO share buyback programme 22 – 28 March 2024
- Mitsubishi Electric Announces Director Candidates
- Bitrue Coin (BTR) Analyzes User Behavior and Announces Upcoming Developments to Enhance Utility
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Goldman Sachs, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!